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Abstract
Unlike other vitamins, the vitamin D concentration in blood varies cyclically over the course of the year in relation to genetic (gender, ethnicity, 
polymorphisms) and environmental factors (sunlight exposure, diet, food-related or direct vitamin D supplementation, skin pigmentation). Altho-
ugh the major diagnostics manufacturers have recently developed improved automated 25-hydroxy vitamin D immunoassays, the intra- and inter-
laboratory variability is still high (especially at low vitamin D concentrations) which might lead to incorrect vitamin D deficiency/insufficiency dia-
gnosis. Moreover, despite recent efforts to standardize the assay and minimize its variability, the current bias for measured vitamin D concentrations 
is often still above the desirable ± 10% criterion. Because the implications of low vitamin D concentrations in non-skeletal diseases are still partially 
unknown, international guideline recommendations for establishing meaningful ranges, at any time over the course of the year, irrespective not 
only of environmental and personal factors but also of instrumental variability, are needed. In this review, we discuss the main factors that influence 
the variability of vitamin D concentrations and whether a centile curve, individually calculated by a theoretical equation considering such factors, 
might be better suited than a fixed limit to assess abnormal vitamin D concentrations in otherwise healthy subjects. Vitamin D reference ranges du-
ring pregnancy, childhood, or diagnosed illnesses, which merit separate discussion, are beyond the scope of this review.
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The term vitamin D refers to a group of related ster-
oid hormones involved in several physiological pro-
cesses centred on the maintenance of calcium ho-
meostasis, but also of phosphate, iron, and zinc, 
through its binding to the vitamin D receptor (VDR) 
(1). After binding the high-affinity vitamin D metab-
olite 1,25-dihydroxyvitamin, the receptor under-
goes homodimerization and heterodimerization to 
a retinoic acid X receptor (RXR) (2). These complexes 
recognize specific DNA sequences that regulate the 
transcription of genes encoding proteins that medi-
ate calcium and skeletal metabolism: osteocalcin, 
osteopontin (SPP1) and bone sialoprotein (BSP) are 
involved in the mineralization of the bony extracel-
lular matrix (ECM); membrane calcium channel 
TRPV6 is involved in intestinal calcium absorption; 
parathyroid hormone (PTH) and the PTH-related 
protein (PTHrp) are involved in calcium homeosta-
sis and vitamin D activation; receptor antagonist of 
nuclear factor kappa-B ligand (RANKL) is involved in 
osteoblast-osteoclast cross-talk in bone as well as in 
the immune regulation of osteoclastogenesis; low-
density lipoprotein receptor-related protein 5 
(LRP5) is involved in Wnt signalling in bone and in 
other Wnt-dependent tissues; cystathionine-β-
synthase (CBS) catalyses the first step of transsulfu-
ration of L-homocysteine in L-cystathionine; as well 
as many others (3-5). Vitamin D also increases intes-
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tinal calcium absorption by inducing the expression 
of calbindin, a calcium-binding protein that partici-
pates in calcium transport across the cell (2). Vita-
min D is also involved in the homeostasis of other 
ions like iron, manganese and zinc by regulating the 
expression of the SLC39A2 gene which plays an im-
portant role in iron homeostasis and the SLC30A10 
gene which encodes the metal transporter ZnT10 
(6-8).
There are two forms of vitamin D: vitamin D3 and 
vitamin D2 (Figure 1). Upon cutaneous exposure to 
ultraviolet B (UVB) radiation, cholecalciferol (vita-
min D3) is synthesized from the photochemical 
ring-opening and subsequent thermal isomeriza-
tion of the precursor 7-dehydrocholesterol (provi-
tamin D) by endogenous synthesis (9). Vitamin D3 
is hydroxylated to form 25-hydroxy vitamin D3 
(25(OH)D, calcidiol), the major circulating human 
vitamin D metabolite, which is then catalysed in 
the liver by the enzyme 25-hydroxylase (CYP2R1) 
(10). Further hydroxylation activated by the en-
zyme 1-α-hydrolase occurs in the kidney to pro-
duce the biologic active form 1,25-dihydroxyvita-
min D3 (1,25(OH)2D3, calcitriol) (10). Vitamin D2 (er-
gocalciferol), which accounts for a smaller amount, 
is of exogenous origin and derives from dietary 
sources such as plants or fish. Like vitamin D3, vita-
min D2 is metabolized in the liver and the kidneys 
to form 1,25-dihydroxyvitamin D2 (1,25(OH)2D2) 
(10,11). The abundance of 25(OH)D and 1,25(OH)2D 
is enzymatically regulated by the enzyme CY-
P24A1 which, by adding a hydroxyl group in posi-
tion 24, lowers the concentrations of both metab-
olites (12). Vitamin D deficiency can cause rickets in 
infants and osteomalacia in adults, increasing the 
risk of osteoporotic fractures (13). Since UVB radia-
tion is necessary to synthesize cholecalciferol, vita-
min D deficiency in populations living at high lati-
tudes is common especially in winter. However, vi-
tamin D deficiency has become increasingly com-
mon also among populations living at lower lati-
tudes owing to the changes brought about by the 
adoption of modern lifestyle habits (e.g., less out-
door activity, greater usage of sunscreens) often as-
sociated with not meeting daily UVB requirements 
(14-16). Physical activity seems to be another im-
portant factor in the determination of vitamin D 
concentrations, as documented by the surprisingly 
high prevalence of vitamin D insufficiency, and 
even deficiency, in professional athletes regardless 
of amounts of the sunlight exposure during indoor 
or outdoor activities (17-19). Because vitamin D plays 
a vital role in bone health, inflammation and immu-
nity, skeletal muscle contraction, neuromuscular 
communication, and cardiovascular function, it is 
plausible that a suboptimal vitamin D status in-


















Figure 1. Vitamin D synthesis.
7-dehydrocholesterol (provitamin D) photoreacts in the skin to 
produce cholecalciferol (vitamin D3). Ergocalciferol (introduced 
with diet) and cholecalciferol are transformed in calcidiol, by 
the enzymes present in the liver. The final hydroxylation step 
exerted by the enzyme CYP27B1, to produce the active form of 
vitamin D (calcitriol), occurs primarily in the kidney.
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toms and inflammatory disease (20). Other factors 
that may impair the synthesis of active D-metabo-
lites (25-(OH)D, 1,25-(OH)2D and 24,25-(OH)2D) in 
athletes include skin pigmentation, early- or late-
day training, indoor training, geographic location, 
and extensive sunscreen usage (17).
At present, serum total 25(OH)D is considered the 
best biomarker for assessing vitamin D status (21). 
It is measured by summing the 25-hydroxylated 
form of the exogenous D2 and the endogenous 
D3, also called 25(OH)D2 and 25(OH)D3, respec-
tively, both of which have the same biological im-
portance. Although 25(OH)D is not the active me-
tabolite, it is characterized by a longer circulating 
half-life than 1,25-(OH)2D and it is not dependent 
on PTH which, instead, controls the enzymatic hy-
droxylation at C1 (17). From an analytical point of 
view, 25(OH)D2 and 25(OH)D3 can be discriminat-
ed by chromatographic techniques or mass spec-
trometry, whereas full or partial cross-reactivity is 
observed when using immunoassay-based meth-
ods. Importantly, unless a patient is taking vitamin 
D supplementation, 25(OH)D2 usually accounts for 
less than 5% of total 25(OH)D (22,23). Based on in-
ternational measurement standards, serum total 
25(OH)D concentration must be reported in na-
nomoles per liter (nmol/L); however, the use of the 
unit nanograms per milliliter (ng/mL) is very com-
mon, especially in the United States. A 2.6 multipli-
cation factor can be used to convert ng/mL into 
nmol/L (24).
In the bloodstream, most 25(OH)D is bound to vi-
tamin D binding proteins (VDBP) and only a small 
amount circulates in its free active form and, 
hence, is able to bind to the VDR (25). Since so 
many environmental and genetic factors can influ-
ence vitamin D synthesis, defining a reliable desir-
able range remains challenging. Furthermore, be-
cause of its hydrophobic nature, its high affinity 
for VDBP, and analytical difficulties, which will be 
discussed below, 25(OH)D has been defined as a 
“difficult analyte” (26-28). Accordingly, the number 
of publications on how to measure vitamin D has 
increased in the past decade. To date, only Austral-
ia uses a reference range that takes seasonal varia-
tion into account (29). There is no agreement on 
the normal ranges for serum total 25(OH)D: the 
U.S. Institute of Medicine (IOM) suggested a mini-
mal concentration of 52 nmol/L, while the Endo-
crine Society (ES) suggested a minimal concentra-
tion 78 nmol/L (13,30,31). Having such diverse cut-
off levels will obviously affect patient categoriza-
tion.
In this review we discuss the environmental, ge-
netic, and instrumental factors that may influence 
the measured concentrations of total 25(OH)D and 
whether a variable range might be more suited 




Because of its biosynthetic pathway, vitamin D 
concentration is highly dependent on UVB radia-
tion dose (Figure 1) and varies seasonally at lati-
tudes distant from the equator (32). In general, the 
maximum amount of total serum 25(OH)D in pop-
ulations living in the northern hemisphere is high-
er in summer and autumn and lower in winter and 
spring (16,33-35). O’Neil et al. showed that the “vi-
tamin D winter”, defined as the time of year when 
UVB doses are insufficient to promote vitamin D 
synthesis, lasts for up to 8 months at latitudes be-
tween 60 and 70° N, 5 to 6 months at latitudes be-
tween 51 and 59° N, and 2 months or does not oc-
cur at all at latitudes between 35 and 40° N (33). 
Krzywanski et al. published interesting data about 
the 25(OH)D concentration in a group of Polish 
athletes divided into two groups according to 
whether they were engaged in outdoor sports 
(OUTD) or indoor sports (IND) (16). Additional sub-
groups were created by dividing the athletes who 
trained during winter months in countries at lower 
latitudes like South Africa or Tenerife (SUN) and 
those who, having inadequate vitamin D status (< 
78 nmol/L), were supplemented orally (SUPL). The 
results showed that the mean value during the 
course of the year in the IND group was always be-
low the 78 nmol/L (minimal concentration suggest-
ed by the ES), whereas the OUT group had mean 
concentrations of 94 ± 3 nmol/L, slightly above the 
minimal concentration, but only in the summer. 
Furthermore, during the winter, both the SUN and 
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the SUPL group had higher 25(OH)D than the OUT 
group by 85% (~ 120 nmol/L) and 45% (~ 100 
nmol/L), respectively, bringing their vitamin D con-
centrations above the minimal concentration (16). 
Comparably, we have recently demonstrated that 
the prevalence of vitamin D insufficiency is high in 
Italian soccer players, despite the latitude, and that 
25(OH)D concentrations follow the classical circan-
nual rhythm regardless of the effort spent (36).
Latitude-related lower UVB availability does not al-
ways correspond to an increased prevalence of vi-
tamin D deficiency, as shown in the study by 
O’Neill et al. (33). Among adults living in northern 
European countries like Iceland and Norway, there 
were fewer cases (2 - 9%) of vitamin D deficiency 
in winter as compared to their counterparts living 
in middle European countries like Ireland (23%). 
The probable reason is dietary habits: in Norway 
and Iceland the traditional diet includes large use 
of fatty fish and cod liver oil and consumption of 
other vitamin D supplements is more common 
(37,38). At lower latitudes, in contrast to the recom-
mendations recently published by the European 
Food Safety Authority (EFSA) on dietary reference 
values for vitamin D, supplementation is still un-
common (39). This hypothesis is further substanti-
ated by the fact that Norwegian adolescents (aged 
13 years), who follow less traditional dietary habits, 
had, on average, a vitamin D concentrations 26 
nmol/L lower than adults (33). Even more surpris-
ingly were the results by Katrinaki et al. obtained 
on the population of Crete. Although the UVB 
availability allows for basically no vitamin D winter, 
the mean 25(OH)D concentrations were below the 
deficiency cut-off level of 52 nmol/L for both males 
and females (50.7 ± 26 and 46.8 ± 24 nmol/L, re-
spectively) (40). This was mainly explained by the 
fact that vitamin D supplementation is seldom 
used in Greece (either direct or food-related) and 
by the islanders’ darker skin pigmentation which 
shields them against UVB radiation. We might also 
speculate that people living in very hot climates 
may prefer to spend more time indoors than their 
counterparts living at higher latitudes where sum-
mers are generally cooler by comparison (41).
Due to their increasing popularity, a particular 
mention should be done for vegetarian and vegan 
diets. Several studies all over the world have 
shown that vegetarians and vegans are particular-
ly exposed to vitamin D insufficiency and deficien-
cy (42,43). Also lactovegetarians and lactoovoveg-
etarians show lower concentrations of 25(OH)D 
compared to non-vegetarians (44,45). Vegetarians 
and vegans, hence, are recommended to supple-
ment their vitamin D intake. However, since vita-
min D3 is derived from animal sources, vegans 
who, instead, prefer the plant-derived vitamin D2 
avoid it. Actually, there are controversies about the 
equivalence of these two forms of vitamin D 
(23,46-48).
In contrast to vitamin D deficiency, toxic concen-
trations of total 25(OH)D may cause hypercalcemia 
(49). Although hypercalcemia does not normally 
occur at concentrations below 260 nmol/L, we 
could exploit the high dependence of vitamin D 
synthesis on UVB radiation to define a safe upper 
limit based on healthy subjects having maximal 
UVB exposure. For instance, in native populations 
living at equatorial latitudes 25(OH)D concentra-
tions range between 60 nmol/L and 177 nmol/L 
(27). Similarly, healthy subjects not living at the 
equator but having very high sunlight exposure 
(like surfers, tanners and outdoor workers) show 
25(OH)D concentrations ranging between 73 
nmol/L and 177 nmol/L. Based on these data, we 
can assume that 25(OH)D concentrations of 170-
180 nmol/L could be considered as a safe range for 
healthy people who are often exposed to high 
UVB doses (27).
From a diagnostic point of view, when measuring 
25(OH)D concentration, the circannual rhythm of 
this metabolite should be considered to avoid re-
percussions on the diagnosis of vitamin D insuffi-
ciency or deficiency. For example, in a patient with 
summer/autumn values slightly above the mini-
mal threshold suggested by the IOM or the ES, the 
winter/spring values will probably fall below the 
desirable range. However, except for the Australi-
an guidelines, the current reference ranges for this 
metabolite do not include seasonal variation; in-
stead, a single measurement taken at any time of 
the year is used to extrapolate the patient’s vita-
min D status throughout the year (29).
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Genetics
Genome-wide association studies have shown 
that single nucleotide polymorphisms (SNP) in the 
vitamin D pathway genes (DHCR7, CYP2R1, CY-
P3A4, CYP27A1, DBP, LRP2, CUB, CYP27B1, CYP24A1, 
VDR, and RXRA) influence vitamin D status (50-52). 
While the vitamin D concentration is tightly regu-
lated by the expression level of the enzymes in-
volved in its activation and inactivation pathways, 
such factors account for approximately 5% of total 
25(OH)D variability (10,50). Consequently, SNPs in 
the CYP2R1 and DHCR7 genes encoding the en-
zymes involved in the first steps of 25(OH)D bio-
synthesis are of limited importance, yet they have 
been consistently shown to alter vitamin D status. 
The most studied SNPs are rs10741657 G>A in the 
CYP2R1 gene which is associated with higher cir-
culating concentrations of 25(OH)D, and 
rs12785878 G>T in the DHCR7 gene which is, in-
stead, associated with lower circulating 25(OH)D 
(50,53-56). In contrast, circulating concentrations of 
VDBP can sequestrate up to 90% of total 25(OH)D 
(57). Because the bioactive form of vitamin D is its 
free circulating form, it has been proposed that 
high levels of VDBP may lower the concentration 
of free 25(OH)D and therefore inhibit its physio-
logical role. As expected, mutations in genes en-
coding VDBP are the most widely investigated, 
and a number of SNPs have been consistently as-
sociated with altered concentrations of vitamin D. 
Among others, the most extensively studied are 
the rs4588 and rs7041 genetic polymorphisms 
which are associated with increased risk of vitamin 
D deficiency particularly in East Asian population 
(57,58-62). Variants of VDBP differ markedly be-
tween racial groups. For instance, rs1155563 and 
rs2298849 are associated with lower vitamin D 
concentrations in African population whereas SNP 
in the rs17467825, also lowering the concentration 
of vitamin D, are more frequently found in Euro-
pean population respectively (51,63-65). In gener-
al, black Americans have lower concentrations of 
25(OH)D and VDBP than their white counterparts, 
despite similar concentrations of bioavailable 
(free) 25(OH)D (66). The interdependency between 
VDBP and 25(OH)D concentrations does not seem 
to have a linear relationship but rather becomes 
significant at low concentrations of 25(OH)D. For 
instance, high VDBP concentrations have been 
correlated with the risk of colorectal cancer (CRC) 
only in patients with low 25(OH)D concentrations, 
suggesting that in individuals with normal 25(OH)D 
concentrations the VDBP concentration does not 
significantly influence the bioavailable vitamin D 
(25). In other words, the higher the VDBP concen-
trations are, the greater is the amount of bound 
25(OH)D; this would lead to reduced concentra-
tions of free and bioavailable 25(OH)D. It follows 
that the impact of high VDBP concentrations is 
more pronounced in conditions of low total 
25(OH)D.
Age, gender, BMI and ethnicity
A recent study by Vuistiner et al. reported that 
gender has little influence on 25(OH)D concentra-
tions (34). Similarly, the effect of age was negligi-
ble in adults. A separate discussion, which is be-
yond the scope of this review, concerns pregnant 
women in which low 25(OH)D concentrations are 
observed worldwide, children, in whom vitamin D 
deficiency can cause rickets and might be a risk 
factor for future chronic diseases, and persons 
with diagnosed illnesses (27,67).
Vuistiner et al. also showed that body-mass index 
(BMI) is inversely correlated to vitamin D concen-
trations. This is mostly due to a decrease in time 
spent in outdoor activities, inadequate diet, and 
the sequestration of vitamin D by subcutaneous 
fat (68). As mentioned above, although many of 
the published studies have been conducted on 
white people, 25(OH)D concentrations may differ 
substantially depending on skin pigmentation. 
Since the main source of vitamin D is exposure to 
sunlight, dark skin shields against UVB radiation, 
increasing the risk for vitamin D deficiency (69). 
For instance, populations of African origin differ in 
skin darkness primarily due to the ratio of eumela-
nin to pheomelanin (70). This difference has ge-
netically evolved because of the different UVB re-
gimes present in their countries of origin and 
might pose a higher risk of developing vitamin D 
deficiency in people of African ethnicity living at 
higher latitudes (71,72). Similarly, genetic variants 
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of VDBP can be observed between racial groups 
(73). These factors should be taken into account 
when measuring total serum 25(OH)D in different 
ethnic groups, particularly in those living at lati-
tudes greatly different than those of their ances-
tors (27).
Analytical variability
Precise measurement of vitamin D concentrations 
is difficult, and large variations exist between dif-
ferent assay methodologies. Such variations de-
pend on several factors: different methods of vita-
min D extraction, antibody cross-reactivity with 
epimers and/or other vitamin D metabolites, and 
presence of isobaric compounds or matrix inter-
ferences (17,21). Table 1 lists the assays most com-
monly used in clinical laboratories. The assays can 
be divided in two main categories: 1) assays based 
on a chromatographic separation step, the most 
popular of which are liquid chromatography-mass 
spectrometry (LC/MS) or liquid chromatography-
tandem mass spectrometry (LC-MS/MS), and 2) 
non-chromatographic methods based on anti-
body or protein binding, such as immunoassays. 
The chromatography-based assays are more con-
sistent and accurate than the antibody-based 
methods. Since the above mentioned methods 
are usually based on achiral chromatographic 
techniques, they cannot distinguish between 
25(OH)D3 and its 3-epimer (which concentrations 
are high in infants but represent only 6% of total 
measured 25(OH)D in adults), or other isobaric 
compounds such as 7-α-hydroxy-4-cholesten-3-
one (an endogenous precursor of bile acids) result-
ing in a slight overestimation of vitamin concen-
trations (74). This problem can be overcome, how-
ever, by appropriate (i.e. chiral phase) chromato-
graphic separation (75). 
In order to promote laboratory measurement 
standardization and reduce variability of vitamin D 
measurement, in 2010 the Office of Dietary Sup-
plements (ODS) of the U.S. National Institutes of 
Health (NIH) organized the Vitamin D Standardiza-
tion Programme (VDSP) (76). This Programme also 
involves the National Institute for Standards and 
Technology (NIST), the Centers for Disease Control 
and Prevention (CDC), the Vitamin D External 
Quality Assessment Scheme (DEQAS), the College 
of American Pathologists (CAP), the American As-
sociation for Clinical Chemistry (AACC), and the In-
ternational Federation of Clinical Chemistry and 
Laboratory Medicine (IFCC). The VDSP is now mon-
itoring performance, accrediting laboratories en-
gaged in vitamin D assays, and developing a 
standard reference measurement procedure 
(SRMP) system which consists of a set of compo-
nents and procedure that can be used to calibrate 
the clinical laboratory instrumentation similarly to 
the Standard Reference Materials (SRMs) previous-
ly produced by the NIST (24,77). On the same line, 
the CDC provides a vitamin D standardization cer-
tification programme and publishes a list of those 
manufacturers/laboratories that have successfully 
passed the performance criterion (± 5% mean bias 
and overall imprecision of < 10% over the concen-
tration range of 22 - 275 nmol/L for total 25(OH)D). 
An additional resource to standardize small clinical 
and research laboratories, as an alternative to the 
CDC programme, which is expensive and more 
suited for manufacturers and large laboratories, 
are the accuracy‐based performance testing (PT) 
programs offered by the CAP and the DEQAS. The 
latter distributes quarterly five serum samples 
with 25(OH)D concentrations previously deter-
mined by the NIST to registered laboratories. The 
laboratories then return their results for quality as-
sessment by the DEQAS (78).
Although much effort has gone in improving ac-
curacy and precision in 25(OH)D measurements, 
two recent studies have highlighted substantial 







LC-MS/MS - liquid chromatography-tandem mass spectrometry.
Table 1. Currently used vitamin D methods
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different commercially available instrumentations 
(26,27). Both studies compared the results ob-
tained by LC-MS with 5 automated chemilumines-
cent immunoassays (CLIA) from different manufac-
turers (Abbott Diagnostics, Diasorin, IDS, Roche 
Diagnostics, and Siemens) and found that the 
mass-spectrometry instrumentation has the best 
performance with a bias < 10%, even at a concen-
tration as low as 5.2 nmol/L. In contrast, most im-
munoassays had a bias greater than ± 15%, and as 
large as 30% in some cases. Only the Liaison in-
strument from Diasorin showed a bias of only 
6.4%, which is comparable with that of LC-MS 
methods. However, the immunoassay biases in-
creased dramatically at low vitamin D concentra-
tions (< 21 nmol/L): the bias increased up to 35% 
for the Liason, whereas for the other instruments it 
exceeded 100% (26).
The large discrepancies between LC-MS methods 
and immunoassays, but also among different im-
munoassay methods, is mainly due to the differ-
ences in cross-reactivity with various vitamin D 
metabolites, which accounts for a significant pro-
portion of total 25(OH)D (27,79). Although immu-
noassays do not detect 3-epi-25(OH)D3, generat-
ing specific antibodies against small antigenic 
molecules such as 25(OH)D is challenging, and 
cross-reactivity with 24,25(OH)2D3 (a product of 
the vitamin D catabolic pathway that can be pre-
sent at concentrations of up to 13 nmol/L) and 
other metabolites of the vitamin D pathway is 
common (10,80). While some immunoassays can-
not detect 25(OH)D2, those that can are unable to 
distinguish between 25(OH)D2 and 25(OH)D3, 
making it difficult to determine abnormalities. Fur-
thermore, the strongly hydrophobic 25(OH)D is 
largely bound to VDBPs in blood which compete 
with the antibody in assays where 25(OH)D and 
VDBP are not completely separated; manual ex-
traction can overcome this problem but increases 
imprecision (26).
The DEQAS noted a substantial improvement in 
the accuracy and precision of vitamin D measure-
ments after the release of the NIST SRM reference 
in 2008 (81). Figure 2 shows how the inter-labora-
tory imprecision has dropped dramatically since 
then and nicely correlates with the rise in the num-
ber of participants in the Assessment Scheme (78). 
As illustrated in Figure 3, and consistent with the 
studies by Farrell and Fuleihan discussed above, 
the mean bias (from the NIST-assigned target val-
ues) for a total of 50 samples distributed between 
2012 and 2014 has not changed much during this 
3-year time period. However, while the LC-MS/MS 
and HPLC/UV methods have a lower bias (within ± 
15 %), and except for the Diasorin Liaison which 
has a bias comparable with the LC-MS methods, 
the other tested immunoassay instruments have 
biases as high as ± 30 % (78). To overcome the 
problem associated with substantial inter-labora-
tory variability, the VDSP conducted a retrospec-
tive standardization by analysing stored samples 
available from two national studies: The Third Na-
tional Health and Nutrition Examination Survey 
(NHANES III, 1988–1994) and the German Health 
Interview and Examination Survey for Children 
and Adolescents (KIGGS, 2003–2006) (82,83). The 
retrospective standardization showed that the vi-
tamin D values were overestimated in NHANES III 
and underestimated in KIGGS. When properly ap-
plied, the assay standardization proposed by the 
VDSP can greatly improve the interpretation of re-
search data. Nonetheless, we are still far from hav-
ing a worldwide vitamin D assay standardization 
that is capable to provide reliable measurements 

















































Figure 2. Relationship between the mean inter-laboratory 
imprecision (line and dotted plot) and the number of DEQAS 
(25-Hydroxyvitamin D measurements) registered laboratories 
(white bars). Gray bars indicates the numbers of returned re-
sults. With permission from DEQAS.
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Figure 3. Changes in % bias from the NIST assigned values for each of the major 25(OH)D methods. 40 samples were distributed 
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2 lists the main advantages and limitations of MS-
based methods and immunoassays for vitamin D 
measurement.
Reference ranges
Measuring 1,25-(OH)2D in serum is more difficult 
than measuring its precursor 25(OH)D due to its 
peculiar properties: highly lipophilic, highly insta-
ble, presence at picomolar concentrations within 
the circulation, below the detection limits of direct 
UV or MS methods. Moreover, the immunoassay-
based determination of 1,25(OH)2D is affected by 
the cross-reactivity of antibodies with other vita-
min D metabolites thus requiring chromatograph-
ic sample pre-purification processes, with exten-
sive manipulation of the sample (84). Serum 
25(OH)D is thus considered the best indicator of 
the vitamin D status even because, contrarily to 
1,25(OH)2D, it is not dependent on PTH and direct-
ly reflect the entity of the vitamin D stores (18). 
Current guidelines from scientific bodies recom-
mend the measurement of 25-hydroxy vitamin D 
(25(OH)D) in blood as the preferred test, however, 
because the total serum 25(OH)D concentration 
has several subject-specific and environmental-
dependent sources of variability, the adoption of a 
fixed desirable range is inappropriate. The main 
biological source of variability arises from the tight 
dependence between UVB exposure and 25(OH)D 
concentration, resulting in a wide variability of vi-
tamin D concentrations over the course of the 
year. This should be considered when measuring 
vitamin D in individual patients, because summer 
values slightly above the desirable range of 52 
nmol/L, as suggested by the IOM, will probably fall 
below such concentrations in the wintertime. Ide-
ally, subject-specific factors related to UVB availa-
bility (e.g., outdoor activity, apparel, skin pigmen-
tation, use of sunscreens, living latitude, and win-
ter holidays at low latitudes) should be taken into 
account to calculate the desirable range. Other 
factors to be considered are: ethnicity, BMI, and 
food-related or direct vitamin D supplementation.
Although the short-term biological variability (6 
weeks) for 25(OH)D is less than 7%, its concentra-
tions vary, on average, by 40 nmol/L during the 
year, with peak changes of up to 105 nmol/L 
(34,85). Fohner et al. showed that in healthy sub-
jects living at high latitudes more than 50% of the 
biological variability for vitamin D could be ex-
plained by relatively few factors (e.g., age, diet, 
gender, season of sample collection, BMI, latitude, 
and genotype), while the remaining variability 
could be ascribed to vitamin D supplementation 
(86). Similarly, Rees et al. analysed a multivariable 
model and showed that few factors (sex, baseline 
serum 25(OH)D, adherence to contraceptive pill in-
take, apparel, physical activity, use of extra vitamin 
D-containing supplements, and season of blood 
collection) accounted for 50% of vitamin D varia-
bility after cholecalciferol supplementation (87). In 
addition, BMI was associated with baseline serum 
25(OH)D but not with its response to supplemen-
Method Advantages Limitations
MS-based
•	 high sample volume (LC-MS)
•	 availability of reference measurement procedures
•	 separation of vitamin D metabolites
•	 allows the inclusion of stable isotope-labelled 
standards
•	 not intended for routine clinical samples analysis
•	 not fully automated
•	 complex and expensive instrumentation
•	 no distinction between epimers
Immunoassays
•	 high sensitivity
•	 reduced sample volume
•	 fully automated
•	 cross-reactivity with other vitamin D metabolites 
(e.g., D2 vs. D3)
•	 measurement of free 25(OH)D requires VDBP 
displacement (proprietary methods)
LC-MS – liquid chromatography-mass spectrometry. VDBP - vitamin D binding proteins.
Table 2. Advantages and limitations of MS-based methods and immunoassays for vitamin D measurement
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tal cholecalciferol, and genetic factors did not play 
a major role, either. Veugelers et al. who proposed 
three different Recommended Dietary Allowances 
(RDA) for normal weight, overweight, and obese 
patients, reported a relationship between BMI and 
vitamin D supplementation (88).
In light of these studies, it appears that the desira-
ble range for vitamin D should be calculated using 
a validated equation that takes into account the 
UVB-component, ethnicity, BMI, age, sex, and 
eventually vitamin D supplementation. Recently, 
predictive models have been developed that take 
into account seasonal variability and ethnicity, and 
seasonal variability and BMI (34,89). In the former 
study, O’Neil et al. proposed a predictive model 
(Figure 4) that, by combining the effect of seasonal 
variability and a component accounting for food-
related or direct supplement vitamin D fortifica-
tion, successfully predicted the measured winter-
time 25(OH)D concentration for both white and 
black Asian minority ethnicity (BAME) population 
groups (89). In another work by Vuistiner et al., the 
data from more than 7000 people were used to 
create a population-based model that predicts the 
centiles of the 25(OH)D distribution by gender, 
age, BMI, and taking seasonal variation into ac-
count. The model can be used to predict future 
values of an individual over the course of the year 
based on a measurement made on a given day. 
The study involved only white Caucasians to avoid 
the vitamin D variability caused by differences in 
ethnical skin pigmentation (34). When the deter-
minants of vitamin D concentrations are different, 
as for example, two different ethnicities or very 
different latitudes, the predictive model has to be 
modified accordingly. Additionally, predictive 
models can be implemented by including popula-
tion-pharmacokinetic models, as described by Oc-
ampo-Pelland et al. (90). The available mathemati-
cal models seems to be more predictive of vitamin 
D concentrations in healthy subjects whereas for 
diseased individuals, or in case of specific physio-
logical conditions (e.g. pregnancy), the adoption 
of a unique equation might be inappropriate and, 
in these cases, more frequent measurements of 
serum 25(OH)D should be the preferred option. 
A separate issue concerns instrumental variability 
which closely depends on the type of assay used. 
Although the VDSP is making great effort to re-
duce the within-assay and between-assay variabil-
ity, the DEQAS review shows that, except for LC-
MS, the bias for the majority of the currently used 
instrumentations (see Table 1) is still high and is 
likely to influence treatment decision making (78).
Conclusions
The prevalence of vitamin D deficiency and insuf-
ficiency is high, and may possibly increase in the 
future. Therefore, it is desirable to include assess-
Figure 4. Predictive model proposed by Vuistiner et al. (34) for 25(OH)D concentrations. 
The model was set according to the Bayesian Information Criterion (BIC). Body-mass index (BMI) was transformed using an inverse 
square-root function t(x) = − 1/√x. Model’s coefficients were as follows: β0 = − 2.754 (P = 0.295), β1 = − 1.077 (P < 0.001), β2 = − 0.756 (P 
< 0.001), β3 = 0.188 (P < 0.001), β4 = 0.025 (P = 0.368), β5 = − 81.08 (P = 0.002), β6 = − 165.6 (P = 0.014), β7 = − 1174 (P ≤ 0.001), β8= 0.218 
(P < 0.001), and β9 = 0.164 (P = 0.003). The model explained 29% of the variance.
25 (OH)D = β0 + β1 sin
2π (day – 1)
365 )
)
+ β5 t (BMI)
2 + β7 I (male)I (BMI < 25) (t(BMI – t(25))
2
+ β2 cos + β3 sin
2π (day – 1)
365 )
) 4π (day – 1)
365 )
)
+ β4 cos + β5 t (BMI)
4π (day – 1)
365 )
)
2π (day – 1)
365 )
) 2π (day – 1)
365 )
)
+ β8 I (female) sin + β9 I (female) cos
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ment of vitamin D in routine examination in order 
to monitor its concentrations and to follow up 
eventual supplementation regimens. Provided 
that accurate 25(OH)D value can be measured, the 
desirable range should be extrapolated, in individ-
ual patients, by an equation considering the time 
of the year, sun exposure, ethnicity, BMI, the type 
of assay used and possible intake of vitamin D, that 
can predict the 25(OH)D centile curve for an 
healthy subject. The discrepancy between the 
predicted value and the measured 25(OH)D con-
centration, at any time of the year, will be then 
safely used to determine an accurate diagnosis on 
the patient vitamin D status. If such equations 
have been developed for otherwise healthy indi-
viduals, additional parameters or completely dif-
ferent equations will be needed to assess individu-
al situations like pregnancy, childhood, or diag-
nosed illnesses.
Although the situation has substantially improved 
through the efforts of the VDSP, what is still lack-
ing is a general standardization, or at least a har-
monization, of methods that provide comparable 
and, more importantly, less biased results. Ideally, 
all measurements should be performed using LC-
MS; however, this scenario being impracticable, 
we encourage clinical laboratories to adopt an as-
say traceable to the gold SRMP as proposed by the 
VDSP in order to calibrate their new and, if availa-
ble, old measurements (91,92).
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